Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 20(21)2019 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-31653045

RESUMO

Chronic renal failure involving hemodialysis results in blood loss during filtration. Iron deficiency and iron deficiency anemia can result. A compensatory increase in iron dosage has many side effects including discomfort. Elemental iron is a highly-pure iron source, which reduces the frequency of dosages; the solubility decreases with increased particle size or pore size. In this study, synthesized mesoporous iron particles (MIPs) were used to relieve iron deficiency anemia. Their bioavailability was measured in vitro by a Caco-2 cell model and in vivo in iron-deficient rats. In vitro bioavailability of MIPs was examined by measuring ferritin content in the Caco-2 cell model. Iron uptake of MIPs was significantly higher than commercial iron particles, which were less porous. In vivo bioavailability of MIPs was examined by measuring body weight gain and red blood cell-related parameters, compared with the bioavailability of standard drug ferrous sulfate in iron-deficient anemic rats. Finally, average hemoglobin content and hemoglobin regeneration efficiency were significantly higher in anemic rats supplemented with commercial iron particles, compared to anemic controls. In the 28-day oral toxicity test, MIPs were not significantly toxic to rat physiology or tissue histopathology. Thus, MIPs may allow effective recovery of hemoglobin in iron deficiency anemia.


Assuntos
Anemia Ferropriva/tratamento farmacológico , Ferro/química , Nanopartículas/uso terapêutico , Administração Oral , Anemia Ferropriva/patologia , Animais , Materiais Biocompatíveis/química , Materiais Biocompatíveis/farmacocinética , Materiais Biocompatíveis/uso terapêutico , Peso Corporal/efeitos dos fármacos , Células CACO-2 , Sobrevivência Celular/efeitos dos fármacos , Modelos Animais de Doenças , Ferritinas/análise , Ferritinas/metabolismo , Compostos Ferrosos/farmacologia , Compostos Ferrosos/uso terapêutico , Hemoglobinas/metabolismo , Humanos , Masculino , Nanopartículas/química , Nanopartículas/metabolismo , Tamanho da Partícula , Porosidade , Ratos , Ratos Wistar , Proteína da Zônula de Oclusão-1/metabolismo
2.
Nanotechnology ; 29(37): 375101, 2018 Sep 14.
Artigo em Inglês | MEDLINE | ID: mdl-29920184

RESUMO

HepG2 cell death with magnetic hyperthermia (MHT) using hydroxyapatite nanoparticles (mHAPs) and alternating magnetic fields (AMF) was investigated in vitro. The mHAPs were synthesized as thermo-seeds by co-precipitation with the addition of Fe2+. The grain size of the HAPs and iron oxide magnetic were 39.1 and 19.5 nm and were calculated by the Scherrer formula. The HepG2 cells were cultured with mHAPs and exposed to an AMF for 30 min yielding maximum temperatures of 43 ± 0.5 °C. After heating, the cell viability was reduced by 50% relative to controls, lactate dehydrogenase (LDH) concentrations measured in media were three-fold greater than those measured in all control groups. Readouts of toxicity by live/dead staining were consistent with cell viability and LDH assay results. Measured reactive oxygen species (ROS) in cells exposed to MHT were two-fold greater than in control groups. Results of cDNA microarray and Western blotting revealed tantalizing evidence of ATM and GADD45 downregulation with possible MKK3/MKK6 and ATF-2 of p38 MAPK inhibition upon exposure to mHAPs and AMF combinations. These results suggest that the combination of mHAPs and AMF can increase intracellular concentrations of ROS to cause DNA damage, which leads to cell death that complement heat stress related biological effects.


Assuntos
Durapatita/química , Hipertermia Induzida , Nanopartículas de Magnetita/química , Espécies Reativas de Oxigênio/metabolismo , Morte Celular , Regulação para Baixo/genética , Regulação Neoplásica da Expressão Gênica , Células Hep G2 , Humanos , Campos Magnéticos , Nanopartículas de Magnetita/ultraestrutura , Regulação para Cima/genética , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA